Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Lin

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Biopreservation and Biobanking|September 9, 2024
A Review of Regulatory Frameworks for Biobanking in Southeast AsiaPlebeian B Medina, Subasri Armon, Mohammad Firdaus Bin Abdul Aziz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Journal of Infectious Diseases|September 4, 2020
Exportation of Monkeypox Virus From the African ContinentMatthew R Mauldin, Andrea M McCollum, Yoshinori J Nakazawa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2020
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyA Henderson, D L Paterson, M D Chatfield, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Biopreservation and Biobanking|September 9, 2024
A Review of Regulatory Frameworks for Biobanking in Southeast AsiaPlebeian B Medina, Subasri Armon, Mohammad Firdaus Bin Abdul Aziz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Journal of Infectious Diseases|September 4, 2020
Exportation of Monkeypox Virus From the African ContinentMatthew R Mauldin, Andrea M McCollum, Yoshinori J Nakazawa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2020
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyA Henderson, D L Paterson, M D Chatfield, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Pageof 16